Becker's Healthcare November 18, 2021
National pharmacies, retail health clinics, physician practices and trial tech companies are emerging as significant disruptors to the traditional clinical trial delivery model, according to a November PwC report.
COVID-19 disrupted the process of conducting clinical trials at hospitals and academic medical centers, giving the biopharma industry a chance to accelerate delivery approaches through methods including local, at-home and virtual options.
These new entrants have access to larger numbers of patients; PwC’s Health Research Institute found that 67 percent of consumers said they are less likely to participate in a clinical trial for COVID-19 treatment if they had to travel outside of their local area to get to a trial site, according to the report.
“Increased access...
Today's Sponsors
Today's Sponsor